Brief: Anebulo Pharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.11
11/05/2023 14:00
May 11 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL 2023
FINANCIAL RESULTS AND RECENT UPDATES
* ANEBULO PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:nPn8Vn4YCa
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results